Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02447627 · ClinicalTrials.gov registry record
Study of Methodologies to Measure Blood Flow and Oxygenation in Adults With Sickle Cell Disease
A clinical trial, sponsored by Bioverativ Therapeutics.
- Completed
- Registry status
- 38
- Enrollment target
NCT02447627 is a clinical trial that has completed, run by Bioverativ Therapeutics. The registered enrollment target is 38 participants.
The verdict
NCT02447627 has completed, sponsored by Bioverativ Therapeutics.
- COMPLETED
- Registry status
- 38 participants
- Enrollment target
Study Summary
The purpose of the study is to determine whether imaging techniques, such as magnetic resonance imaging (MRI), near infrared spectroscopy (NIRS), laser speckle contrast imaging (LSCI), and optical imaging (OI), can detect differences in blood flow and oxygen levels in different organ systems of participants with sickle cell disease (SCD). Differences in blood flow and oxygen levels detected by these techniques will be evaluated to determine their utility as biomarkers of clinical disease pathophysiology.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2015-06 |
| Est. Completion | 2016-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02447627
The ClinicalTrials.gov registry entry for NCT02447627 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bioverativ Therapeutics, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02447627 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02447627 about?
NCT02447627 is a clinical study titled "Study of Methodologies to Measure Blood Flow and Oxygenation in Adults With Sickle Cell Disease". The purpose of the study is to determine whether imaging techniques, such as magnetic resonance imaging (MRI), near infrared spectroscopy (NIRS), laser speckle contrast imaging (LSCI), and optical imaging (OI), can detect differences in blood flow and oxygen levels in different organ systems of part...
What is the current status of trial NCT02447627?
This trial is currently completed. The enrollment target is 38 participants. The study started on 2015-06. Estimated completion is 2016-10.
Who is sponsoring clinical trial NCT02447627?
This trial is sponsored by Bioverativ Therapeutics, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.